2nd Quarter - Report
THE DUBERSTEIN GROUP INC. for AMGEN INC
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures - HR 6 21st Century Cures Act. Vial size pharmaceuticals - S3040-Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Medicare/Medicaid MMM
Medicare Part B pricing. Centers for Medicare and Medicaid Demonstration project regarding drug prices. Executive Action
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
Natural Resources NAT
Puerto Rico restructuring: HR5278, PROMESA; S2328, PROMESA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KENNETH DUBERSTEIN | — |
| BRIAN GRIFFIN | — |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.